Eisai Inc v. Sanofi Aventis U.S. LLC, et al

Track this case

Case overview

Case Number:

14-2017

Court:

Appellate - 3rd Circuit

Nature of Suit:

3410 Antitrust

Sectors & Industries:

  1. June 08, 2016

    3rd Circ. Won't Take Second Look At Lovenox Antitrust Suit

    The Third Circuit on Wednesday denied a bid by pharmaceutical company Eisai Inc. to have the full court revisit a panel's earlier decision not to revive an antitrust suit against Sanofi-Aventis U.S. LLC over the anticoagulant Lovenox.

  2. May 19, 2016

    Eisai Asks 3rd Circ. To Rehear Lovenox Antitrust Suit

    Pharmaceutical company Eisai asked the full Third Circuit on Wednesday to revisit the company's bid to revive an antitrust suit against Sanofi, arguing that the panel set a harmful precedent for consumers by allowing Sanofi to enter arrangements with hospitals that effectively excluded competition for the anticoagulant Lovenox.

  3. January 13, 2015

    Eisai Pushes 3rd Circ. To Revive Sanofi Antitrust Suit

    Pharmaceutical manufacturer Eisai Inc. on Tuesday asked the Third Circuit to reinstate its antitrust lawsuit against Sanofi-Aventis U.S. LLC over discount contracts with hospitals that purchased large amounts of its anticoagulant drug Lovenox, arguing the company improperly worked to raise the price of competitors.